Uze; Gilles
Patent Applications and Registrations
Patent applications and USPTO patent grants for Uze; Gilles.The latest application filed is for "immune-cell targeted bispecific chimeric proteins and uses thereof".
Company Profile
8.21.25
- Uze; Gilles - Montpellier FR
- UZE; Gilles - Gent BE
- Uze; Gilles - Ghent BE
- Uze; Gilles - Paris FR
Patent Activity
| Patent | Date |
|---|---|
| Targeted modified TNF family members Grant 11,396,532 - Tavernier , et al. July 26, 2 | 2022-07-26 |
| Immune-cell Targeted Bispecific Chimeric Proteins And Uses Thereof App 20220226441 - TAVERNIER; Jan ; et al. | 2022-07-21 |
| Fusokines involving cytokines with strongly reduced receptor binding affinities Grant 11,358,997 - Tavernier , et al. June 14, 2 | 2022-06-14 |
| Immune-cell targeted bispecific chimeric proteins and uses thereof Grant 11,246,911 - Tavernier , et al. February 15, 2 | 2022-02-15 |
| Targeting Of Human Interferon Antagonists App 20210238247 - TAVERNIER; Jan ; et al. | 2021-08-05 |
| Targeted Human-interferon Fusion Proteins App 20210162010 - TAVERNIER; Jan ; et al. | 2021-06-03 |
| Targeted and mutated human-interferon fusion proteins Grant 10,946,070 - Tavernier , et al. March 16, 2 | 2021-03-16 |
| Targeting of human interferon antagonists Grant 10,947,288 - Tavernier , et al. March 16, 2 | 2021-03-16 |
| Targeted modified TNF family members Grant 10,787,493 - Tavernier , et al. September 29, 2 | 2020-09-29 |
| Targeted Modified Tnf Family Members App 20200262884 - TAVERNIER; Jan ; et al. | 2020-08-20 |
| Targeted Modified Il-1 Family Members App 20200255545 - Kind Code | 2020-08-13 |
| Fusokines involving cytokines with strongly reduced receptor binding affinities Grant 10,640,542 - Tavernier , et al. | 2020-05-05 |
| Targeted Modified Tnf Family Members App 20190367575 - TAVERNIER; Jan ; et al. | 2019-12-05 |
| Immune-cell Targeted Bispecific Chimeric Proteins And Uses Thereof App 20190351021 - TAVERNIER; Jan ; et al. | 2019-11-21 |
| Targeted modified TNF family members Grant 10,407,480 - Tavernier , et al. Sept | 2019-09-10 |
| Targeted Modified Il-1 Family Members App 20190202934 - TAVERNIER; Jan ; et al. | 2019-07-04 |
| Fusokines Involving Cytokines With Strongly Reduced Receptor Binding Affinities App 20190010199 - TAVERNIER; Jan ; et al. | 2019-01-10 |
| Targeting Of Cytokine Antagonists App 20180334489 - TAVERNIER; Jan ; et al. | 2018-11-22 |
| Targeting Of Cytokine Antagonists App 20180334488 - TAVERNIER; Jan ; et al. | 2018-11-22 |
| Targeted Human-interferon Fusion Proteins App 20180333465 - Tavernier; Jan ; et al. | 2018-11-22 |
| Targeted Modified Tnf Family Members App 20180298074 - TAVERNIER; Jan ; et al. | 2018-10-18 |
| Targeting of human interferon antagonists Grant 10,072,059 - Tavernier , et al. September 11, 2 | 2018-09-11 |
| Targeted modified TNF family members Grant 10,035,835 - Tavernier , et al. July 31, 2 | 2018-07-31 |
| Targeted human-interferon fusion proteins Grant 10,034,919 - Tavernier , et al. July 31, 2 | 2018-07-31 |
| Targeted Modified Il-1 Family Members App 20180186894 - Tavernier; Jan ; et al. | 2018-07-05 |
| Targeted Modified TNF Family Members App 20180170989 - Tavernier; Jan ; et al. | 2018-06-21 |
| Fusokines Involving Cytokines with Strongly Reduced Receptor Binding Affinities App 20180155404 - TAVERNIER; Jan ; et al. | 2018-06-07 |
| Targeted modified IL-1 family members Grant 9,932,409 - Tavernier , et al. April 3, 2 | 2018-04-03 |
| Targeted modified TNF family members Grant 9,914,759 - Tavernier , et al. March 13, 2 | 2018-03-13 |
| Targeting Of Cytokine Antagonists App 20180057555 - Tavernier; Jan ; et al. | 2018-03-01 |
| Targeted Human-interferon Fusion Proteins App 20180028616 - Tavernier; Jan ; et al. | 2018-02-01 |
| Targeted human-interferon fusion proteins Grant 9,878,014 - Tavernier , et al. January 30, 2 | 2018-01-30 |
| Targeting of human interferon antagonists Grant 9,732,135 - Tavernier , et al. August 15, 2 | 2017-08-15 |
| Lentiviral-based Vector And Its Use In Directed Evolution Of Genomic Regions, Genes And Polynucleotides App 20170073672 - NEGRONI; Matteo ; et al. | 2017-03-16 |
| Targeted Mutant Alpha-helical Bundle Cytokines App 20170072020 - Tavernier; Jan ; et al. | 2017-03-16 |
| Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides Grant 9,518,271 - Negroni , et al. December 13, 2 | 2016-12-13 |
| Targeted human-interferon fusion proteins Grant 9,492,562 - Tavernier , et al. November 15, 2 | 2016-11-15 |
| Targeted Modified TNF Family Members App 20160159874 - Tavernier; Jan ; et al. | 2016-06-09 |
| Targeting of Cytokine Antagonists App 20160159875 - Tavemier; Jan ; et al. | 2016-06-09 |
| Targeted Modified IL-1 Family Members App 20160152730 - Tavernier; Jan ; et al. | 2016-06-02 |
| Targeted Mutant Alpha-helical Bundle Cytokines App 20140348789 - Tavernier; Jan ; et al. | 2014-11-27 |
| Lentiviral-based Vector And Its Use In Directed Evolution Of Genomic Regions, Genes And Polynucleotides App 20120264616 - Negroni; Matteo ; et al. | 2012-10-18 |
| Purified human alpha interferon receptor Grant 5,889,151 - Mogensen , et al. March 30, 1 | 1999-03-30 |
| Use of the alpha interferon receptor and cells which express the receptor, for identification of alpha interferon agonists Grant 5,861,258 - Mogensen , et al. January 19, 1 | 1999-01-19 |
| cDNA fragment coding the alpha interferon receptor gene and process for the preparation of a corresponding protein Grant 5,731,169 - Mogensen , et al. March 24, 1 | 1998-03-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 